Oral belinostat: Phase I/II started

TopoTarget said investigators began an open-label, Danish Phase I/II trial to evaluate daily oral

Read the full 149 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE